About iMFLUX

iMFLUX, a wholly owned subsidiary of Procter & Gamble, is transforming the future of plastic injection molding.

With iMFLUX, sites run more reliably with fewer operator adjustments.

Manufacturers can produce higher quality parts, reduce costs, and lower capital – all while advancing sustainability efforts.

iMFLUX provides the way to autonomous molding with a new capability to design and mold that impossible part. The revolutionary low-constant-pressure injection molding platform works with virtually any plastic injection machine, material, and mold.

For specific questions or more information, please email us.


Follow us on LinkedIn and Twitter